Stay updated on Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Sign up to get notified when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.

Latest updates to the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe page now shows a new revision label v3.5.4, replacing the previous v3.5.3, indicating a deployment update to the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a minor site software/version update rather than a change to the study details, eligibility, or outcomes.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded a resource entry for Multiple myeloma linking to the Genetic and Rare Diseases Information Center in the Resources section.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check69 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Dara-Thal-Dex in Relapse Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.